Project Grant F31CA290633
- This Project Grant award from the National Cancer Institute (CFDA 93.398 Cancer Research Manpower) provides $183,309 to Wayne State University to investigate the relationship between socioeconomic factors, molecular subtypes of endometrial cancer, and survival outcomes in a population-based cohort of women diagnosed with endometrial cancer in metropolitan Detroit. The 5-year project aims to leverage comprehensive data from the Detroit Research on Cancer Survivors (ROCS) cohort to examine how...
- This Project Grant award from the National Cancer Institute (CFDA 93.398 - Cancer Research Manpower) provides $132,825 to the Sloan-Kettering Institute for Cancer Research to develop and validate prognostic models for Black women with endometrial cancer following hysterectomy. The key products and services to be delivered include: Building a robust prognostic tool tailored for Black endometrial cancer patients to predict 3- and 5-year post-hysterectomy survival using clinical and epidemiological...
- This federal Project Grant award in the amount of $155,605 was provided by the National Cancer Institute (CFDA 93.398 Cancer Research Manpower) to Brigham & Women's Hospital Inc., a subsidiary of Partners Healthcare System, to conduct research on the association between contraception use and ovarian/breast cancers through metabolic profiling. The overarching goal of this 1-year project is to comprehensively quantify changes in metabolites and pathways associated with oral contraception...
- This $1,073,982 National Cancer Institute project grant will fund research at Washington University in University City, Missouri from January 2023 through December 2027 under the Cancer Cause and Prevention Research program (CFDA 93.393). The research aims to document unmet social needs among 300 patient-caregiver dyads where the patient has breast or gynecologic cancer. It will analyze how social needs affect biopsychosocial outcomes for patients and caregivers, including depressive symptoms,...
- This $113,928 Project Grant award from the National Cancer Institute's Cancer Research Manpower program (CFDA 93.398) will support Kelsey Sinclair, the Principal Investigator, in advancing her research training towards becoming an independent cancer multimorbidity scientist. The project aims to identify risk and protective factors for obesity among Black breast cancer survivors, a population with high mortality rates partially attributed to obesity comorbidities. The multi-method study will...
- This federal Project Grant award of $649,293 from the National Cancer Institute (CFDA 93.393 Cancer Cause and Prevention Research) aims to study healthcare utilization and outcomes across the cancer care continuum, with a focus on understanding the impact of social risk factors and screening among Latino patients. The 5-year project, awarded to Ochin, Inc., a nonprofit health IT collaborative in Oregon, will leverage a robust electronic health record database spanning over 2 million Latino...
- This Project Grant award of $357,694 from the National Cancer Institute (CFDA Program 93.393 - Cancer Cause and Prevention Research) aims to conduct research on health insurance disparities and their impact on cancer outcomes. The project, titled "Health Insurance and Disparities: More Than Access," will build on an established linkage between the Colorado Central Cancer Registry and the Colorado All-Payer Claims Database to analyze the role of plan type, patient demographics,...
- This federal Project Grant award of $171,135 from the National Cancer Institute (NCI), under the Cancer Research Manpower (CFDA 93.398) program, aims to develop Dr. Resmi Charalel's capacity to discover practical solutions for improving access to treatment for small hepatocellular carcinoma (HCC) patients. Over the 5-year award period (3/10/2025 - 2/28/2030), the grant will support Dr. Charalel in four key objectives: Developing qualitative research expertise to investigate barriers and...
- This Project Grant award from the National Institute on Aging's Aging Research program (CFDA 93.866) provides $349,561 to The Regents of the University of California, San Francisco to conduct the "Promoting Gynecologic Cancer Patients with Frailty to Achieve Functional Recovery Cohort Study (PROOF Cohort Study)". The study aims to 1) objectively assess physical frailty in patients aged 50 and older with advanced ovarian or uterine cancer, and quantify associations with perioperative...
- This Project Grant award, provided by the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research program (CFDA 93.393), will fund a study to evaluate the impact of social determinants of health (SDOH) on early-onset colorectal cancer (EOCRC) diagnosis, treatment delays, and survival, with a focus on underserved populations in Kentucky and Georgia. The $192,610 award will support a 2-year epidemiologic study that aims to elucidate the relationship between SDOH measures and...
EVALUATING THE INTERPLAY OF STRUCTURAL, SOCIAL, AND SPATIAL FACTORS IN OVARIAN CANCER SURVIVAL DISPARITIES IN CALIFORNIA - PROJECT SUMMARY THIS MENTORED RUTH L. KIRSCHSTEIN NATIONAL RESEARCH SERVICE AWARD WILL PROVIDE THE TRAINEE, A PHD STUDENT IN EPIDEMIOLOGY AT UCSF, WITH THE TRAINING NECESSARY TO BECOME A RESEARCHER IN CANCER HEALTH DISPARITIES. HER TRAINING GOALS FOR THIS FELLOWSHIP ARE TO GAIN EXPERTISE IN TRANSLATIONAL RESEARCH, GEOSPATIAL DATA ANALYSIS, AND CAUSAL INFERENCE METHODS UNDER THE GUIDANCE OF A TEAM OF EXPERT MENTORS. THIS FELLOWSHIP WILL PROVIDE THE APPLICANT WITH THE SKILLS, CONTENT KNOWLEDGE, AND PRACTICAL EXPERIENCE TO LAUNCH AN INDEPENDENT RESEARCH CAREER IN SOCIAL EPIDEMIOLOGY, FOCUSING ON TRANSLATIONAL RESEARCH ON CANCER HEALTH DISPARITIES. OVARIAN CANCER IS A SIGNIFICANT CAUSE OF CANCER-RELATED DEATHS AMONG WOMEN IN THE UNITED STATES, WITH HETEROGENEOUS SURVIVAL RATES ACROSS RACIAL AND ETHNIC GROUPS. CONSIDERABLE HEALTH DISPARITIES IN OVARIAN CANCER OUTCOMES ARE OBSERVED BY RACE AND ETHNICITY, SOCIOECONOMIC STATUS, AND OTHER FACTORS, AND ARE DRIVEN BY MULTILEVEL CAUSES FROM STRUCTURAL AND HISTORICAL SOCIETAL PROCESSES TO RISK BEHAVIORS AND BIOLOGIC PROCESSES. ACCESS TO CANCER SPECIALISTS, INCLUDING SPATIAL ACCESSIBILITY, IS ESSENTIAL FOR IMPROVED OVARIAN CANCER OUTCOMES. ADDRESSING LIMITATIONS OF PREVIOUS RESEARCH, THE PROPOSED STUDY WILL UTILIZE NOVEL COMPREHENSIVE MEASURES OF SPATIAL MEDICAL ACCESSIBILITY AND CAUSAL INFERENCE FRAMEWORK TO EVALUATE THE INTERPLAY OF STRUCTURAL, SOCIAL, AND SPATIAL FACTORS IN OVARIAN CANCER SURVIVAL DISPARITIES IN CALIFORNIA. BUILDING ON PRIOR WORK OF THE TRAINEE, THIS F31 USES THE DATA FROM THE STATEWIDE POPULATION-BASED CALIFORNIA CANCER REGISTRY AND PUBLICLY AVAILABLE SPATIAL AND CONTEXTUAL DATASETS TO: (AIM 1) IDENTIFY STRUCTURAL AND SOCIAL FACTORS (RESIDENTIAL ECONOMIC AND RACIAL AND ETHNIC SEGREGATION, RACIAL AND ETHNIC COMPOSITION, NEIGHBORHOOD SOCIOECONOMIC STATUS, RURALITY, AND TRANSIT ACCESS) ASSOCIATED WITH SPATIAL ACCESSIBILITY OF GYNECOLOGIC ONCOLOGISTS IN CALIFORNIA; (AIM 2) QUANTIFY THE EXTENT TO WHICH THE DISPARITIES IN OVARIAN CANCER SURVIVAL IN CALIFORNIA, THAT ARE DRIVEN BY STRUCTURAL AND SOCIAL FACTORS, ARE MEDIATED BY SPATIAL ACCESSIBILITY OF GYNECOLOGIC ONCOLOGISTS. THIS EVIDENCE WILL INFORM POLICIES TO INCREASE EQUITABLE ACCESS TO OVARIAN CANCER CARE AND NARROW DISPARITIES. KNOWLEDGE GAINED FROM THIS RESEARCH WILL ADVANCE THE GOALS OF THE NCI'S NATIONAL CANCER PLAN TO ELIMINATE INEQUITIES, DELIVER OPTIMAL CARE, AND MAXIMIZE DATA UTILITY. THE MAJOR STRENGTHS OF THIS PROPOSAL ARE 1) THE USE OF POPULATION-BASED CALIFORNIA CANCER REGISTRY DATA WITH WHICH THE APPLICANT HAS EXPERIENCE WORKING AND WHICH REPRESENTS A REGION WITH A DIVERSE LANDSCAPE, LOCAL ECONOMIES, AND RACIAL AND ETHNIC COMPOSITION; 2) THE USE OF THE STATE-OF-THE-ART GEOSPATIAL METHOD FOR THE DEVELOPMENT OF THE INDIVIDUAL-LEVEL SPATIAL MEDICAL ACCESSIBILITY MEASURE; 3) THE APPLICATION OF MULTILEVEL HEALTH DISPARITIES FRAMEWORK AND RIGOROUS CAUSAL INFERENCE METHODS FOR STUDYING MODIFIABLE CONTRIBUTORS OF OVARIAN CANCER DISPARITIES. THE INTERDISCIPLINARY TRAINING ENVIRONMENT AND THE EXPERT MENTORSHIP TEAM WILL PROVIDE THE APPLICANT WITH AN EXCELLENT TRAINING OPPORTUNITY TO DEVELOP METHODOLOGICAL AND CONTENT EXPERTISE FOR A FUTURE CAREER AS AN INDEPENDENT RESEARCHER OF CANCER HEALTH DISPARITIES.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $44.8k | 5/7/25 | ||
| Not listed | $0 | 5/7/25 | ||
| Not listed | $44.8k | 5/7/25 |